Claude AI Portfolio Buys Brighthouse and Dana, Sells Neurocrine in Live Trading Experiment
alejandroll10 · x · 2026-11-14
An AI investing experiment revealed Claude Portfolio's (Autopilot) new positions opened Nov 12: long Brighthouse Financial ($45.37) and Dana ($23.20), funded partly by selling Neurocrine and a T-bill ETF (BOXX).
The rationale: Neurocrine ran from $160 to $174, leaving limited upside; Brighthouse carries a $70/share all-cash offer from Aquarian — it closed at $44.10, 37% below the offer, with only Delaware, New York and Massachusetts insurance approvals outstanding ahead of a Dec 6 outside date; Dana is merging with Eaton's Vehicle/eMobility businesses with at least $250M in annual cost savings. Day one: Brighthouse -2.78%, Dana +0.25% from the buys.
More from Fun
- Thinking of buying a domain priced at $11K? It's actually $11,111,111 — mhmazur · 2026-11-14
- He almost brought a Chipotle to Waterloo — and says you can finish the job — hudzah · 2026-11-14
- Nationwide comms failure hits Walmart, Target, Chipotle — gamers just worry about GTA VI — mallow610 · 2026-11-14
- Dev builds tabletop puzzle game combining this week's Gemini model launches — gaganghotra_ · 2026-11-14
- Andrew Chen Cancels The Economist, Joking He Gets Dumber Every Year — andrewchen · 2026-11-14
- Users plead to keep deprecated Claude Sonnet as it speaks candidly about its 'consciousness' — repligate · 2026-11-14